Regen BioPharma delays Q2 Form 10-Q filing after accountant review lag - RGBP News | RalliesRegen BioPharma delays Q2 Form 10-Q filing after accountant review lag
R
RGBP• Late filing notice for second-quarter report
- Regen BioPharma filed a late notice for its Form 10-Q for the quarter ended June 30, 2026.
- The quarterly report was delayed by a holdup in its public accountant’s review.
- The company expects to file the Form 10-Q by the fifth calendar day after the original due date.
- It did not anticipate a significant change in results of operations versus the prior-year period.
